619 related articles for article (PubMed ID: 19828373)
21. Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry.
Husson O; Haak HR; Buffart LM; Nieuwlaat WA; Oranje WA; Mols F; Kuijpens JL; Coebergh JW; van de Poll-Franse LV
Acta Oncol; 2013 Feb; 52(2):249-58. PubMed ID: 23181387
[TBL] [Abstract][Full Text] [Related]
22. Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme.
Gamper EM; Wintner LM; Rodrigues M; Buxbaum S; Nilica B; Singer S; Giesinger JM; Holzner B; Virgolini I
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1179-88. PubMed ID: 25771905
[TBL] [Abstract][Full Text] [Related]
23. EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.
Georgakopoulos A; Kontodimopoulos N; Chatziioannou S; Niakas D
Eur J Oncol Nurs; 2013 Dec; 17(6):849-55. PubMed ID: 23850411
[TBL] [Abstract][Full Text] [Related]
24. Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry.
van der Poel MW; Oerlemans S; Schouten HC; van de Poll-Franse LV
Ann Hematol; 2015 Apr; 94(4):651-61. PubMed ID: 25471174
[TBL] [Abstract][Full Text] [Related]
25. Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry.
Oerlemans S; Issa DE; van den Broek EC; Nijziel MR; Coebergh JW; Mols F; van de Poll-Franse LV
Eur J Haematol; 2014 Sep; 93(3):229-38. PubMed ID: 24702126
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
Taphoorn MJ; van den Bent MJ; Mauer ME; Coens C; Delattre JY; Brandes AA; Sillevis Smitt PA; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; Allgeier A; Bottomley A;
J Clin Oncol; 2007 Dec; 25(36):5723-30. PubMed ID: 18089866
[TBL] [Abstract][Full Text] [Related]
27. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
[TBL] [Abstract][Full Text] [Related]
28. Impact of cancer-related symptom synergisms on health-related quality of life and performance status.
Ferreira KA; Kimura M; Teixeira MJ; Mendoza TR; da Nóbrega JC; Graziani SR; Takagaki TY
J Pain Symptom Manage; 2008 Jun; 35(6):604-16. PubMed ID: 18362059
[TBL] [Abstract][Full Text] [Related]
29. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
Petersen MA; Groenvold M; Aaronson NK; Chie WC; Conroy T; Costantini A; Fayers P; Helbostad J; Holzner B; Kaasa S; Singer S; Velikova G; Young T;
Eur J Cancer; 2010 May; 46(8):1352-8. PubMed ID: 20231085
[TBL] [Abstract][Full Text] [Related]
30. General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.
Pilz MJ; Loth FLC; Nolte S; Thurner AMM; Gamper EM; Anota A; Liegl G; Giesinger JM;
J Patient Rep Outcomes; 2024 May; 8(1):48. PubMed ID: 38695992
[TBL] [Abstract][Full Text] [Related]
31. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
[TBL] [Abstract][Full Text] [Related]
32. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
[TBL] [Abstract][Full Text] [Related]
33. Chronic non-malignant pain patients report as poor health-related quality of life as palliative cancer patients.
Fredheim OM; Kaasa S; Fayers P; Saltnes T; Jordhøy M; Borchgrevink PC
Acta Anaesthesiol Scand; 2008 Jan; 52(1):143-8. PubMed ID: 18005378
[TBL] [Abstract][Full Text] [Related]
34. Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group.
Behringer K; Müller H; Görgen H; Flechtner HH; Brillant C; Halbsguth TV; Thielen I; Eichenauer DA; Schober T; Nisters-Backes H; Fuchs M; Engert A; Borchmann P
Br J Cancer; 2013 Jan; 108(1):49-57. PubMed ID: 23321510
[TBL] [Abstract][Full Text] [Related]
35. Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2 × 2 randomised controlled trial.
Kimman ML; Dirksen CD; Voogd AC; Falger P; Gijsen BC; Thuring M; Lenssen A; van der Ent F; Verkeyn J; Haekens C; Hupperets P; Nuytinck JK; van Riet Y; Brenninkmeijer SJ; Scheijmans LJ; Kessels A; Lambin P; Boersma LJ
Eur J Cancer; 2011 May; 47(7):1027-36. PubMed ID: 21237636
[TBL] [Abstract][Full Text] [Related]
36. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.
Gjorup CA; Groenvold M; Hendel HW; Dahlstroem K; Drzewiecki KT; Klausen TW; Hölmich LR
Eur J Cancer; 2017 Nov; 85():122-132. PubMed ID: 28918186
[TBL] [Abstract][Full Text] [Related]
38. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
39. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation.
Hjermstad MJ; Evensen SA; Kvaløy SO; Loge JH; Fayers PM; Kaasa S
Psychooncology; 2003 Dec; 12(8):803-13. PubMed ID: 14681953
[TBL] [Abstract][Full Text] [Related]
40. Reference data of the EORTC QLQ-C30 questionnaire: five consecutive annual assessments of approximately 2000 representative Dutch men and women.
Mols F; Husson O; Oudejans M; Vlooswijk C; Horevoorts N; van de Poll-Franse LV
Acta Oncol; 2018 Oct; 57(10):1381-1391. PubMed ID: 29912607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
